Replicor is a clinical-stage company developing novel NUCLEIC ACID-BASED POLYMERS (NAPs): oligonucleotides whose antiviral activity is strictly dependent on the polymer chemistry of oligonucleotides which can be preserved independently of the sequence of nucleotides present. NAPs have a very important safety advantage over all other existing oligonucleotide-based drugs such as aptamers, antisense oligonucleotides and siRNA: because NAP’s activity is not sequence dependent, NAPs can be engineered with sequences which retain antiviral activity but which do not have pro-inflammatory activity or off target effects common with other oligonucleotide-based drugs, rendering them safe and well tolerated.

Shenyang Research Institute of Chemical Industry Co. Ltd. is a company headquartered in Shenyang, China and ultimately controlled by the Government of China, specializing in pesticides and agricultural chemicals.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Attobio Pharmaceutical (Suzhou) Co. Ltd. engages in the development of biomedical technology and products. Its business activities include the innovation of products designed to improve the level of preventive medicine and early detection of disease to provide accurate diagnostic techniques, and the import and export of biological reagents and biotechnology. The company was founded by Xiao Jia Chang on May 7, 2012 and is headquartered in Suzhou, China.

Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (doing business as Chia Tai-Tianqing Pharmaceutical Co Ltd) is a company headquartered in Lianyungang, China. The firm manufactures pharmaceutical products. It was founded in 1969. Kang Xin Yu is the current CEO of the firm.

Beijing Sailintai Pharmaceutical Technology Co., Ltd., established on 2006-07-05, Business scope includes technology development,Technical Services,technical consulting,Technology Promotion,technology transfer;Medical Research and Experimental Development;Sell ​​self-developed products;Import and export,Technology Import and Export.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Lianyungang Runzhong Pharmaceutical Co., Ltd., a subsidiary of Sino Biopharmaceutical Ltd., is a company headquartered in Lianyungang, China. The firm manufactures pharmaceutical products.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

LG Life Sciences Ltd. engages in the development, production and marketing medicine and fine chemicals. Its products include growth hormone products, arthritis medicine, diabetes medicine, cosmetic surgery products, hypertension treatment, synthetic medicinal raw materials, and pesticide raw material. The company was founded on August 1, 2002 and is headquartered in Seoul, South Korea.

DDL Diagnostic Laboratory BV operates as a testing and contract research laboratory specializes in molecular diagnostics testing and assay development. Its services include tailor-made diagnostic assays, project management, laboratory services, molecular pathology services, training and consultancy and molecular epidemiology. The company was founded in 1985 and is headquartered in Rijswijk, the Netherlands.

Institut Català d'Oncologia, a subsidiary of Region of Catalonia, is a company headquartered in Barcelona, Spain. The firm operates cancer research institute.

Sinochem Corp. produces and distributes petroleum, fertilizers, rubber, plastics and chemicals products. It also offers energy, agriculture, chemical, real estate, and financial services. The company was founded in 1950 and is headquartered in Beijing, China.

Shenzhen Bolijian Pharmaceutical Co., Ltd., established on 2013-12-11, Business scope includes general business items:Research and Development of Organic Compounds;Research and development of new chemical products(Production without pharmaceuticals,sales and legal,Administrative regulations,The State Council decided to ban,Items requiring approval);Pharmaceutical new technology,Development, promotion and application of new technologies(Does not contain national prohibition,restricted items).,The licensing program is:

KUMHO Engineering & Construction Co., Ltd. engages in the construction business. It operates through the following Business divisions: Architecture, Logistics, Rental, and The Other. THe Architecture division provides civil engineering and construction services. The Logistics division offers air cargo services. The Rental division deals with hotel and real estates rentals. The Other division provides maintenance services of buildings built. The company was founded on September 5, 1960 and is headquartered in Naju, South Korea.

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

CJ CheilJedang is a core subsidiary in charge of the food and bioengineering business Unit of the CJ Group. It has led the development of the Korean food industry for the past 60 years, and contributed to the development of the bioengineering industry as the nation’s top food originated company. After being launched in 1953 as a food ingredient company, continuously extended its business to processed foods. In 2007, CJ CheilJedang divided out as a subsidiary company to concentrate on the food and bioengineering business.

Chiron Corporation (/ˈkaɪrɒn/ KY-ron) was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.